Page 335 - PROGRAMME2018
P. 335

 P-792 Are we losing valuable reserves by discarding post-TESE (testicular sperm extraction) material? Analysis of the quantity and distribution of spermatogonial stem cells (SSCs) after TESE
M. Afshani1, I. Kaplanoglu2, A. Öcal3, Ö. Çınar4
1Eastern Mediterranean University Dr. Fazıl Küçük Faculty of Medicine, Histology and Embryology, Famagusta, Turkey
2Etlik Zübeyde Hanım Gynecology Education and Research Hospital, Assisted Reproductive Techniques and IVF Unit, Ankara, Turkey
3Etlik Zübeyde Hanım Gynecology Education and Research Hospital, Assisted Reproductive Techniques and ART Unit, Ankara, Turkey
4Ankara University School of Medicine, Histology and Embryology, Ankara, Turkey
P-793 Characterization of human granulosa progenitor cells as a potential source for the treatment of chemotherapy-induced ovarian damage
B. Cai1, L. Baomin1, X. Yanwen1, Z. Canquan1
1First Affiliated Hospital of SunYat-sen University, reproductive medicine center, Guangzhou- Guangdong, China
P-794 Feasibility of CRISPR-Cas9 on the human sperm cell
D. Choi1, B. Chin1, C. O'Neill1, S. Cheung1, Z. Rosenwaks1, G. Palermo1
1Weill Cornell Medicine, The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, New York, U.S.A.
P-796 Intrauterine infusion of autologous peripheral blood mononuclear cells in frozen blastocyst transfer improves clinical outcome and metabolomic profile in repeated implantation failure- A pilot study
B. Chakravarty1, S. Wasim1, S. Chakrabarti1, P. Banerjee1, K. Chaudhury2, P. Chakraborty3 1Institute of Reproductive Medicine, Assisted Reproductive Technology, Kolkata, India 2Indian Institute Of Technology, smst, Kharagpur, India
3Institute of Reproductive Medicine, Infertility, Kolkata, India
P-797 Proteomic profiling of the exosomes released by endometrial mesenchymal stem cells: possible relations with embryo development and implantation
F. Marinaro1, V. Alvarez1, R. Blázquez1,2, E. López Nieto1, B. Macías-García3, M. Gómez Serrano4, I. Jorge Cerrudo2,4, J. Vázquez2,4, F.M. Sánchez-Margallo2,5, J. García Casado1,2
1Jesús Usón Minimally Invasive Surgery Centre, Stem cell therapy unit, Cáceres, Spain
2CIBER de Enfermedades Cardiovasculares, CIBER de Enfermedades Cardiovasculares, Madrid, Spain 3Jesús Usón Minimally Invasive Surgery Centre, Assisted reproduction Unit, Cáceres, Spain
4Centro Nacional Investigaciones Cardiovasculares CNIC, Cardiovascular Proteomics Lab, Madrid, Spain
5Jesús Usón Minimally Invasive Surgery Centre, Jesús Usón Minimally Invasive Surgery Centre, Cáceres, Spain
                FINAL PROGRAMME I BARCELONA, SPAIN – 1 TO 4 JULY 2018 335
   POSTERS












































































   333   334   335   336   337